Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. (VNDA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · VNDA · as of Sep 30, 2025
Ownership Breakdown
157
Institutional Holders
▲ 13 vs Q2
$224.63M
Total Inst. Value
▲ $12.19M vs Q2
60.14M
Shares Outstanding
freeFloat 89.54%
44.91M
13F Shares Held
▼ 92,368 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
VNDA largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. pharmaceutical preparations | 8.92M | 15.12% | 15.12% | $44.50B | Nov 12, 2025 | ▼ 517.3K |
VANGUARD GROUP INC pharmaceutical preparations | 3.59M | 6.08% | 6.08% | $17.90B | Nov 7, 2025 | ▲ 14.3K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 3.48M | 5.89% | 5.89% | $17.35B | Nov 13, 2025 | ▲ 29.5K |
MILLENNIUM MANAGEMENT LLC pharmaceutical preparations | 3.25M | 5.51% | 5.51% | $16.22B | Nov 14, 2025 | ▲ 130.5K |
DIMENSIONAL FUND ADVISORS LP pharmaceutical preparations | 2.56M | 4.35% | 4.35% | $12.79B | Nov 12, 2025 | ▼ 21.8K |
TANG CAPITAL MANAGEMENT LLC pharmaceutical preparations | 2.35M | 3.99% | 3.99% | $11.74B | Nov 14, 2025 | — held |
ACADIAN ASSET MANAGEMENT LLC pharmaceutical preparations | 2.23M | 3.78% | 3.78% | $11.12B | Nov 13, 2025 | ▲ 496.9K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 1.39M | 2.36% | 2.36% | $6.95B | Nov 12, 2025 | ▼ 299.6K |
STATE STREET CORP pharmaceutical preparations | 1.27M | 2.15% | 2.15% | $6.34B | Nov 14, 2025 | ▲ 5.2K |
KRENSAVAGE ASSET MANAGEMENT, LLC pharmaceutical preparations | 1.18M | 2.00% | 2.00% | $5.89B | Nov 17, 2025 | ▲ 155.5K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
22
Increased
+2.89M shares2
New Positions
first time holders21
Decreased
−2.01M shares0
Sold Out
fully exitedNet shares change (top 50)
+877.9K
+2.89M / −2.01M
Net new holders
+3
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
VNDA insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
1
Sell transactions
1.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Mitchell Stephen Ray director | May 18, 2026 | Gift | 25,836 | — | — | 71.2K | Form 4 ↗ |
Duncan Charles Cliff director | Apr 22, 2026 | Award | 57,101 | — | — | 57.1K | Form 4 ↗ |
Williams Timothy SVP & General Counsel | Mar 2, 2026 | Sale | 42,434 | $8.27 | $350.8K | 377.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Vanda Pharmaceuticals Inc. (VNDA) is primarily owned by institutional investors, who hold approximately 74.7% of total shares outstanding. Company insiders own approximately 10.46%, while retail and public investors account for the remaining 14.86%.
The largest institutional shareholder of Vanda Pharmaceuticals Inc. is BLACKROCK, INC., holding approximately 8.92 million shares — equal to 15.12% of outstanding shares — as of September 30, 2025.
A total of 157 institutional investors currently hold VNDA stock, with a combined institutional value of approximately $224,625,819 as of the most recent 13F filing period.
Frequently asked questions
VNDA ownershipVanda Pharmaceuticals Inc. (VNDA) is primarily owned by institutional investors, who hold approximately 74.7% of shares. The largest shareholder is BLACKROCK, INC. with a 15.12% stake. Company insiders hold 10.46%. Data sourced from SEC Form 13F as of September 30, 2025.